Know Cancer

or
forgot password
  • cancer clinical trials in southington, CT

  • IGIV Study for Chronic ITP Patients Ages 3-70
    Cancer Center of Central Connecticut
    Southington, Connecticut
    Idiopathic Thrombocytopenic Purpura
    Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
    Cancer Center of Central Connecticut
    Southington, Connecticut
    Breast Cancer
    Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
    Cancer Center of Central Connecticut
    Southington, Connecticut
    B-Cell Chronic Lymphocytic Leukemia (B-CLL)
    Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
    Cancer Center of Central Connecticut
    Southington, Connecticut
    Relapsed or Refractory Chronic Lymphocytic Leukemia
    A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
    Cancer Center of Central Connecticut
    Southington, Connecticut
    Acute Myeloid Leukemia
    Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
    Cancer Center of Central Connecticut
    Southington, Connecticut
    Follicular Lymphoma
    LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
    1200.125.10058 Boehringer Ingelheim Investigational Site
    Southington, Connecticut
    Carcinoma, Non-Small-Cell Lung
    Afatinib Expanded Access Program
    1200.45.003 Boehringer Ingelheim Investigational Site
    Southington, Connecticut
    Carcinoma, Non-Small-Cell Lung
    Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
    Cancer Center of Central Connecticut, Site #147
    Southington, Connecticut 06489
    Chronic Myeloid Leukemia
    A Phase 2 of GS-9973 in Subjects With Relapsed or Refractory Hematologic Malignancies
    Cancer Center of Central Connecticut
    Southington, Connecticut
    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma, Indolent Non-Hodgkin's Lymphoma
    A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
    Cancer Center of Central Connecticut
    Southington, Connecticut
    Acute Myelogenous Leukemia
    A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)
    Cancer Center of Central Connecticut
    Southington, Connecticut
    Acute Myelogenous Leukemia, Acute Myeloid Leukemia
    Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
    Cancer Center of Central Connecticut
    Southington, Connecticut
    Breast Neoplasms
    An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
    Cancer Center of Central Connecticut
    Southington, Connecticut
    Pancreatic Cancer
    Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma
    Cancer Center of Central Connecticut
    Southington, Connecticut
    Relapsed Follicular Lymphoma